Michael John Levene

Principal investigator.

Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$6.9MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20172025
AwardsPatents
Federal awards as principal investigator

9 awards · $6.9M

DateAgencyAwardAmountCompany
Aug 21, 2025NIHSBIR Phase II
Commercial Readiness for Direct-to-Digital Pathology
$1.6MAPPLIKATE TECHNOLOGIES, INC.
Aug 9, 2024NIHSBIR Phase II
Commercial Readiness for Direct-to-Digital Pathology
$1.6MAPPLIKATE TECHNOLOGIES, INC.
Jan 8, 2024NIHSBIR Phase II
Commercial Readiness for Direct-to-Digital Pathology
$466KAPPLIKATE TECHNOLOGIES, INC.
Sep 19, 2023NIHSBIR Phase II
Commercial Readiness for Direct-to-Digital Pathology
$225KAPPLIKATE TECHNOLOGIES, INC.
Jun 29, 2020NIHSBIR Phase II
Practical high resolution microscopy of uncut, unembedded kidney biopsies
$472KAPPLIKATE TECHNOLOGIES, INC.
Sep 13, 2019NIHSBIR Phase II
Practical high resolution microscopy of uncut, unembedded kidney biopsies
$484KAPPLIKATE TECHNOLOGIES, INC.
Jan 17, 2019NIHSBIR Phase I
New instrument and methods for fast, diagnostic-quality histology of un-embedded bone marrow and lymph node specimens
$225KAPPLIKATE TECHNOLOGIES, INC.
Jun 27, 2018NIHSBIR Phase II
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
$693KAPPLIKATE TECHNOLOGIES, INC.
Jul 7, 2017NIHSBIR Phase II
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
$1.1MAPPLIKATE TECHNOLOGIES, INC.
Among 4,795 researchers in Medtech

Peer ranks

Federal funding#151
Awards as PI#166
Patents#505
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.